Anxo Pharmaceutical Co., Ltd. (6677.TWO)

TWD 24.7

(-3.14%)

Operating Income Summary of Anxo Pharmaceutical Co., Ltd.

  • Anxo Pharmaceutical Co., Ltd.'s latest annual operating income in 2023 was 53.15 Million TWD , up 426.76% from previous year.
  • Anxo Pharmaceutical Co., Ltd.'s latest quarterly operating income in 2024 Q2 was 17.51 Million TWD , up 200.0% from previous quarter.
  • Anxo Pharmaceutical Co., Ltd. reported an annual operating income of 10.74 Million TWD in 2022, down -70.84% from previous year.
  • Anxo Pharmaceutical Co., Ltd. reported an annual operating income of 36.83 Million TWD in 2021, down -41.75% from previous year.
  • Anxo Pharmaceutical Co., Ltd. reported a quarterly operating income of -17.51 Million TWD for 2024 Q1, down -205.16% from previous quarter.
  • Anxo Pharmaceutical Co., Ltd. reported a quarterly operating income of 9.99 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Operating Income Chart of Anxo Pharmaceutical Co., Ltd. (2023 - 2019)

Historical Annual Operating Income of Anxo Pharmaceutical Co., Ltd. (2023 - 2019)

Year Operating Income Operating Income Growth
2023 53.15 Million TWD 426.76%
2022 10.74 Million TWD -70.84%
2021 36.83 Million TWD -41.75%
2020 63.23 Million TWD 39.3%
2019 45.39 Million TWD 0.0%

Peer Operating Income Comparison of Anxo Pharmaceutical Co., Ltd.

Name Operating Income Operating Income Difference
Allied Biotech Corporation 88.71 Million TWD 40.085%
GeneFerm Biotechnology Co., Ltd. 153.56 Million TWD 65.387%
Easywell Biomedicals, Inc. -162.73 Million TWD 132.662%
TTY Biopharm Company Limited 1.37 Billion TWD 96.127%
Synmosa Biopharma Corporation 614.74 Million TWD 91.354%
Orient EuroPharma Co., Ltd. 84.55 Million TWD 37.137%
Center Laboratories, Inc. -79.26 Million TWD 167.057%
Tien Liang BioTech Co., Ltd. 20.43 Million TWD -160.095%
Orient Pharma Co., Ltd. 27.75 Million TWD -91.522%
InnoPharmax Inc. -64.83 Million TWD 181.977%
Johnson Chemical Pharmaceutical Works Co., Ltd. 105.57 Million TWD 49.652%
Excelsior Biopharma Inc. -81.12 Million TWD 165.517%
DV Biomed Co., Ltd. 173.54 Million TWD 69.373%
Foresee Pharmaceuticals Co., Ltd. -1 Billion TWD 105.275%
Handa Pharmaceuticals, Inc. 695.79 Million TWD 92.361%
UniPharma Co., Ltd. -27.3 Million TWD 294.664%
Alar Pharmaceuticals Inc. 385.52 Million TWD 86.213%
Winston Medical Supply Co., Ltd. 196.1 Million TWD 72.895%
Mercury Biopharmaceutical Corporation -45.69 Million TWD 216.334%
Bioray Biotech Co., Ltd -19.33 Million TWD 374.962%
TSH Biopharm Corporation Limited 63.63 Million TWD 16.466%